Filter
855
Filtered Results: 855
Text search:
Ministry
of
Health
and
Social
Welfare,
Government
of
India
Featured
Recommendations
50
New Publications
289
Language
Document type
No document type
559
Studies & Reports
140
Guidelines
70
Manuals
46
Strategic & Response Plan
15
Fact sheets
9
Training Material
6
Situation Updates
3
Infographics
3
Resource Platforms
2
App
1
Videos
1
Countries / Regions
India
265
Nepal
40
Global
32
Bangladesh
30
Myanmar / Burma
27
Asia
20
South–East Asia Region
18
Indonesia
12
Kenya
11
Nigeria
9
Tanzania
8
Ethiopia
7
Ghana
6
Malawi
6
Uganda
6
Namibia
6
Sierra Leone
5
Liberia
5
China
4
Rwanda
4
Zimbabwe
4
Africa
4
Cambodia
4
Western and Central Europe
4
Pakistan
4
Laos
3
Guinea
3
Congo, Democratic Republic of
3
Russia
3
Botswana
3
Zambia
3
Tajikistan
2
Thailand
2
Ukraine
2
Lesotho
2
Syria
2
Senegal
2
Philippines
2
Mozambique
2
Latin America and the Carribbean
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
South Africa
2
Vietnam
2
Eastern Europe
2
Sri Lanka
2
Bhutan
2
Eswatini/ Swaziland
2
Albania
1
Afghanistan
1
USA
1
Haiti
1
Venezuela
1
Mauritius
1
Bosnia and Herzegovina
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
440
Public Health
47
Key Resources
35
Women & Child Health
34
Clinical Guidelines
32
Capacity Building
5
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
Mental Health
84
Disability
64
HIV
51
COVID-19
51
TB
37
Caregiver
22
Planetary Health
21
NTDs
21
AMR
21
Global Health Education
20
Health Financing Toolbox
11
Rapid Response
10
Refugee
10
Pharmacy
10
NCDs
9
Natural Hazards
8
Conflict
7
Ebola & Marburg
4
Specific Hazards
3
Polio
3
Social Ethics
1
Zika
1
Master of Science in Pharmaceutical Management Dissertation
Implementation guide for national, district and facility levels.
This implementation guide contains practical guidance for policy-makers,
programme managers, health practitioners and other actors working to
establish and implement quality of care (QoC) programmes for maternal,
newborn and child ...
Infant Psychiatry
Chapter B.1
Early Maltreatment and exposure to violence
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
Sixth Meeting of the mhGAP Forum Hosted by WHO in Geneva on 4-5 September 2014 Summary Report
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output and the link between mental disorders and costly, po...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
